169 related articles for article (PubMed ID: 22302130)
1. Conservative treatment of microinvasive adenocarcinoma of uterine cervix: long-term follow-up.
Sopracordevole F; Canzonieri V; Giorda G; De Piero G; Lucia E; Campagnutta E
J Low Genit Tract Dis; 2012 Oct; 16(4):381-6. PubMed ID: 22302130
[TBL] [Abstract][Full Text] [Related]
2. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
3. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
[TBL] [Abstract][Full Text] [Related]
4. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
5. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
7. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.
Bisseling KC; Bekkers RL; Rome RM; Quinn MA
Gynecol Oncol; 2007 Dec; 107(3):424-30. PubMed ID: 17707895
[TBL] [Abstract][Full Text] [Related]
8. Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up.
Yahata T; Nishino K; Kashima K; Sekine M; Fujita K; Sasagawa M; Honma S; Kodama S; Tanaka K
Int J Gynecol Cancer; 2010 Aug; 20(6):1063-6. PubMed ID: 20683418
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
12. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
13. Laser CO(2) conization: a safe mode of treating conservatively microinvasive carcinoma of the uterine cervix.
Diakomanolis E; Haidopoulos D; Rodolakis A; Vlachos G; Stefanidis K; Komisopoulos K; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):229-33. PubMed ID: 15063966
[TBL] [Abstract][Full Text] [Related]
14. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
15. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
[TBL] [Abstract][Full Text] [Related]
16. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
17. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.
Reynolds EA; Tierney K; Keeney GL; Felix JC; Weaver AL; Roman LD; Cliby WA
Obstet Gynecol; 2010 Nov; 116(5):1150-7. PubMed ID: 20966701
[TBL] [Abstract][Full Text] [Related]
18. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.
Wolf JK; Levenback C; Malpica A; Morris M; Burke T; Mitchell MF
Obstet Gynecol; 1996 Jul; 88(1):82-6. PubMed ID: 8684768
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cervical conization as a definitive treatment for borderline lesions of the uterine cervix].
Matsuyama T; Tsukamoto N; Kashimura M; Iwasaka T; Saito T; Uchino H; Nakano H; Matsukuma K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2063-71. PubMed ID: 6512325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
